Image de couverture de livre

Clinical Evaluation of Potential Interaction Between Bemnifosbuvir and Ruzasvir With an Assessment of Food Effect: Results of a Phase 1 Study in Healthy Participants

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Xiao‐Jian Zhou, Gaetano Morelli, Maureen Montrond, Shannan Lynch, Keith Pietropaolo, Bruce Belanger, Arantxa Horga, Janet Hammond
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Clinical Pharmacology in Drug Development
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug Transporters
par: Xiao‐Jian Zhou, et autres
Publié: (2025)

In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug‐Metabolizing Enzymes
par: Xiao‐Jian Zhou, et autres
Publié: (2026)

Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
par: Junyu Xu, et autres
Publié: (2024)

A 2‐Part, Open‐Label, Phase 1 Bioequivalence and Food‐Effect Study of Ubrogepant in Healthy Adult Participants
par: Ramesh Boinpally, et autres
Publié: (2025)

Effect of High‐Fat Food on the Pharmacokinetics and Safety of Amlodipine/Benazepril in Healthy Chinese Participants
par: Congyang Ding, et autres
Publié: (2026)

Taste Profile and Relative Bioavailability of Tovorafenib Powder for Oral Suspension and Food Effect of the Tovorafenib Tablet in Healthy Participants
par: Yang Zhang, et autres
Publié: (2025)

A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants
par: Yohannes Teffera, et autres
Publié: (2025)

Effect of Carbamazepine on the Pharmacokinetics of Erdafitinib in Healthy Participants
par: Pharavee Jaiprasart, et autres
Publié: (2024)

Randomized Phase 1 Studies Evaluating the Safety, Tolerability, Pharmacokinetics, and Target Occupancy of Zampilimab in Healthy Participants
par: Jo Collier, et autres
Publié: (2026)

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies
par: Andrew C. Vendel, et autres
Publié: (2026)

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Bexicaserin in Healthy Participants: A First‐in‐Human Randomized, Double‐Blind, Placebo‐Controlled Single Ascending Dose Escalation Phase 1 Study
par: Rosa Chan, et autres
Publié: (2025)

Pharmacokinetics and Safety Evaluation of a New Generic Sitafloxacin: A Phase I Bioequivalence Study in Healthy Chinese Participants
par: Yongfang Lei, et autres
Publié: (2025)

Phase 1 Studies to Assess Inhaled Seralutinib as a Perpetrator or a Victim of Drug‐Drug Interactions in Healthy Participants
par: Jianke Li, et autres
Publié: (2024)

Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
par: Bridget L. Morse, et autres
Publié: (2025)

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants
par: Matthias Hoch, et autres
Publié: (2025)

Pharmacokinetics of Aztreonam–Avibactam After Single‐ and Multiple‐Dose Administration: A Phase 1, Open‐Label Study in Healthy Chinese Participants and Ethnic Comparison with Non‐Chinese Participants
par: Jingjing Wang, et autres
Publié: (2026)

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study
par: Junyu Xu, et autres
Publié: (2025)

Safety, Tolerability, and Pharmacokinetics of Mufemilast, a PDE4 Inhibitor, in Healthy Participants: A First‐in‐Human Phase 1 Study
par: Xiuqi Li, et autres
Publié: (2026)

Bioequivalence and Food Effect Assessment Between 2 Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Chinese Subjects
par: Kaixian Tang, et autres
Publié: (2025)

Two‐Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants
par: Olivier Schueller, et autres
Publié: (2024)

Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants
par: Hari V. Kalluri, et autres
Publié: (2024)

Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, in Healthy Chinese Participants
par: Jingjing Wang, et autres
Publié: (2025)

Effect of Itraconazole or Rifampin on Zilurgisertib Pharmacokinetics When Administered Orally in Healthy Participants
par: Yan‐ou Yang, et autres
Publié: (2025)

Safety, Tolerability, and Pharmacokinetics of Single‐ and Multiple‐Ascending Doses of Sunobinop in Healthy Participants
par: Alessandra Cipriano, et autres
Publié: (2024)

Pharmacokinetics and Safety of Atogepant Co‐administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open‐Label, Drug‐Drug Interaction Study
par: Ramesh Boinpally, et autres
Publié: (2024)

Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early‐Phase Clinical Study Participants
par: Andrea Francesco Daniele Di Stefano, et autres
Publié: (2025)

Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed‐Dose Combination Product: Phase 1 Results in Healthy Pre‐ and Postmenopausal Women
par: Mong‐Jen Chen, et autres
Publié: (2024)

Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers
par: Bruce L Daugherty, et autres
Publié: (2026)

Relative Bioavailability Studies With Mitapivat: Formulation and Food Effect Assessments in Healthy Subjects
par: Varsha Iyer, et autres
Publié: (2024)

Bioequivalence and Safety Assessment of 2 Formulations of Low‐Dose Metformin Hydrochloride under Fasting Conditions in Healthy Chinese Participants: A Randomized Phase 1 Clinical Trial
par: Ming‐Li Sun, et autres
Publié: (2024)

Effect of High‐Fat Diets on the Pharmacokinetics of Bedaquiline Fumarate Tablet: A Trial in Healthy Chinese Participants
par: Xuanxuan Wang, et autres
Publié: (2025)

Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal Function
par: Mason W. Freeman, et autres
Publié: (2024)

Impact of Food on the Oral Absorption of N‐Acetyl‐D‐Mannosamine in Healthy Men and Women
par: Allan M. Evans, et autres
Publié: (2024)

A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy
par: Randolph P. Matthews, et autres
Publié: (2024)

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double‐Blind, Phase 1 Studies
par: Naihan Chen, et autres
Publié: (2025)

Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants
par: Christian Rask‐Madsen, et autres
Publié: (2024)

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study
par: Vincent Chow, et autres
Publié: (2026)

A Phase 1, Open‐Label, Randomized, Two‐Part Study in Healthy Adult Volunteers to Evaluate the Bioavailability of the Maribavir Powder for Oral Suspension, as Well as Food Effect and Impact of Rabeprazole
par: Olivia Campagne, et autres
Publié: (2024)

A Phase 1 Dose‐Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR‐1505, in Healthy Volunteers
par: Vipul K. Gupta, et autres
Publié: (2026)

A Drug‐Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2‐ and MATE1‐Mediated Transport of Metformin in Healthy Participants
par: Rajinder Bhardwaj, et autres
Publié: (2024)